NDA Insights

Stay updated with the latest information
on drug development. 
You can also sign up to our newsletter to
make sure you don't miss anything.

NDA News & Events
Date Title Author

Accelerated Approval

Accelerated Approval provides patient access to promising new medicines faster based on surrogate measures that aims to predict meaningful clinical benefits.
Read more
30-05-2023

Get to know our experts – Björn Carlsson

In this article, we shine the spotlight on Björn Carlsson, the esteemed Director of the NDA Advisory Board. 
Read more
26-05-2023

Meet Paula Salmikangas & Tatiana Reimer at ISCT 2023

Dr Paula Salmikangas, Director of Biopharmaceuticals and ATMPs at NDA, and Tatiana Reimer, Principal Consultant at NDA, will be presenting different topics at International Society for Cell and Gene Therapy (ISCT) 2023.
Read more
22-05-2023

Why is a potency assay important for cell and gene therapy products?

Paula Salmikangas, Björn Carlsson, Christophe Klumb and Tatiana Reimer together with Prof. Steffen Thirstrup published an article in Frontiers in Medicine, Regulatory Science.
Read more
10-05-2023

MHRA’s Overhaul of UK Clinical Trials: A Comparative Analysis Against EU’s CTIS System

The MHRA is implementing new measures to simplify and accelerate the process of conducting clinical trials in the UK.
Read more
24-04-2023

Get to know our experts – Adriana Andrić

In this article, we shine the spotlight on Adriana Andrić, Senior Consultant at NDA, and learn from her experience of wearing many regulatory hats.
Read more
24-04-2023
Load more

Contact us

Your drug development needs are unique

Contact us to learn how our experts can support you to meet all regulatory, quality and safety requirements and ensure the best path to approval.

Let's Bring Medicines to the World

  • This field is for validation purposes and should be left unchanged.

This website uses cookies

Cookies ("cookies") consist of small text files. The text files contain data which is stored on your device. To be able to place some type of cookies we need your consent. We at NDA Group AB, corporate identity number 556654-3046 use these types of cookies. To read more about which cookies we use and storage duration, click here to get to our cookiepolicy.

Manage your cookie-settings

Necessary cookies

Necessary cookies are cookies that need to be placed for fundamental functions on the website to work. Fundamental functions are for instance cookies that are needed for you to use menus and navigate the website.

Statistical cookies

To know how you interact with the website we place cookies to collect statistics. These cookies anonymize personal data.

Ad measurement cookies

To be able to provide a better service and experience we place cookies to tailor marketing for you. Another purpose for this placement is to market products or services to you, give tailored offers or market and give recommendations on new concepts based on what you have bought from us previously.
Confirm choices Accept all